nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Pilot Trial of Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Docetaxel and the Combination of Bevacizumab (NSC-704865) in Patients With Inoperable Locally Advanced Stage III Non–Small-Cell Lung Cancer: SWOG S0533
|
Wozniak, Antoinette J. |
|
2015 |
16 |
5 |
p. 340-347 8 p. |
artikel |
2 |
Autophagy Inhibition Overcomes the Antagonistic Effect Between Gefitinib and Cisplatin in Epidermal Growth Factor Receptor Mutant Non–Small-Cell Lung Cancer Cells
|
Liu, Jia-Tao |
|
2015 |
16 |
5 |
p. e55-e66 nvt p. |
artikel |
3 |
Bevacizumab, Pemetrexed, and Cisplatin, or Bevacizumab and Erlotinib for Patients With Advanced Non–Small-Cell Lung Cancer Stratified by Epidermal Growth Factor Receptor Mutation: Phase II Trial SAKK19/09
|
Gautschi, Oliver |
|
2015 |
16 |
5 |
p. 358-365 8 p. |
artikel |
4 |
Detection of Crizotinib-Sensitive Lung Adenocarcinomas With MET, ALK, and ROS1 Genomic Alterations via Comprehensive Genomic Profiling
|
Le, Xiuning |
|
2015 |
16 |
5 |
p. e105-e109 nvt p. |
artikel |
5 |
Diminished Disease-Free Survival After Lobectomy: Screening Implications
|
Reich, Jerome M. |
|
2015 |
16 |
5 |
p. 391-397 7 p. |
artikel |
6 |
Editorial Board
|
|
|
2015 |
16 |
5 |
p. A4- 1 p. |
artikel |
7 |
Factors Influencing the Diagnostic Accuracy of Identifying the Histologic Type of Non–Small-Lung Cancer With Small Samples
|
Oikawa, Takefumi |
|
2015 |
16 |
5 |
p. 374-378 5 p. |
artikel |
8 |
Genetic Variants of the MDM2 Gene Are Predictive of Treatment-Related Toxicities and Overall Survival in Patients With Advanced NSCLC
|
Qian, Ji |
|
2015 |
16 |
5 |
p. e37-e53 nvt p. |
artikel |
9 |
Liver Transplantation-Associated Lung Cancer: Comparison of Clinical Parameters and Outcomes
|
Kocher, Florian |
|
2015 |
16 |
5 |
p. e75-e81 nvt p. |
artikel |
10 |
Long-Term Outcomes and Patterns of Failure After Surgical Resection of Small-Cell Lung Cancer
|
Stish, Bradley J. |
|
2015 |
16 |
5 |
p. e67-e73 nvt p. |
artikel |
11 |
Maintenance or Consolidation Therapy for Non–Small-Cell Lung Cancer: A Meta-Analysis Involving 5841 Subjects
|
Zhang, Cuicui |
|
2015 |
16 |
5 |
p. e15-e23 nvt p. |
artikel |
12 |
Overcoming Resistance Without the Risk of Reaction: Use of Afatinib and Panitumumab in Two Cases of Epidermal Growth Factor Receptor–Mutated Non–Small-Cell Lung Cancer With T790M Mutations
|
Castellanos, Emily H. |
|
2015 |
16 |
5 |
p. e97-e99 nvt p. |
artikel |
13 |
Phase I Study of Lapatinib and Pemetrexed in the Second-Line Treatment of Advanced or Metastatic Non–Small-Cell Lung Cancer With Assessment of Circulating Cell Free Thymidylate Synthase RNA as a Potential Biomarker
|
Ramlau, Rodryg |
|
2015 |
16 |
5 |
p. 348-357 10 p. |
artikel |
14 |
Programmed Death-Ligand 1 Expression Predicts Tyrosine Kinase Inhibitor Response and Better Prognosis in a Cohort of Patients With Epidermal Growth Factor Receptor Mutation-Positive Lung Adenocarcinoma
|
Lin, Cheng |
|
2015 |
16 |
5 |
p. e25-e35 nvt p. |
artikel |
15 |
Relationship of Driver Oncogenes to Long-Term Pemetrexed Response in Non–Small-Cell Lung Cancer
|
Liang, Ying |
|
2015 |
16 |
5 |
p. 366-373 8 p. |
artikel |
16 |
Reliability of Small Biopsy Samples Compared With Resected Specimens for the Determination of Programmed Death-Ligand 1 Expression in Non–Small-Cell Lung Cancer
|
Kitazono, Satoru |
|
2015 |
16 |
5 |
p. 385-390 6 p. |
artikel |
17 |
Response to Crizotinib in a Patient With Lung Adenocarcinoma Harboring a MET Splice Site Mutation
|
Jenkins, Russell W. |
|
2015 |
16 |
5 |
p. e101-e104 nvt p. |
artikel |
18 |
Risk of Pneumonitis After Stereotactic Body Radiation Therapy in Patients With Previous Anatomic Lung Resection
|
Hayes, Jason T. |
|
2015 |
16 |
5 |
p. 379-384 6 p. |
artikel |
19 |
Stereotactic Body Radiotherapy for Synchronous Primary Lung Cancer: Clinical Outcome of 18 Cases
|
Shintani, Takashi |
|
2015 |
16 |
5 |
p. e91-e96 nvt p. |
artikel |
20 |
Survival Benefit of Pemetrexed in Lung Adenocarcinoma Patients With Anaplastic Lymphoma Kinase Gene Rearrangements
|
Park, Sojung |
|
2015 |
16 |
5 |
p. e83-e89 nvt p. |
artikel |
21 |
Table of Contents
|
|
|
2015 |
16 |
5 |
p. A11-A16 nvt p. |
artikel |
22 |
The Clinical Use of Genomic Profiling to Distinguish Intrapulmonary Metastases From Synchronous Primaries in Non–Small-Cell Lung Cancer: A Mini-Review
|
Klempner, Samuel J. |
|
2015 |
16 |
5 |
p. 334-339.e1 3057 p. |
artikel |
23 |
Treatment of Elderly Patients With Non–Small-Cell Lung Cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology
|
Gridelli, Cesare |
|
2015 |
16 |
5 |
p. 325-333 9 p. |
artikel |